LivaNova (LIVN) Cash from Investing Activities Growth (1y) (2017 - 2026)
LivaNova (LIVN) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 0.00% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -255.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -255.90% |
| Mar 31, 2026 | -37.18% |
| Dec 31, 2025 | -182.58% |
| Sep 30, 2025 | -24.50% |
| Jun 30, 2025 | 28.65% |
| Mar 31, 2025 | -67.03% |
| Dec 31, 2024 | 11.78% |
| Sep 30, 2024 | -84.21% |
| Jun 30, 2024 | -88.87% |
| Mar 31, 2024 | 44.59% |
| Dec 31, 2023 | -10.82% |
| Sep 30, 2023 | -72.42% |
| Jun 30, 2023 | 58.79% |
| Mar 31, 2023 | -109.49% |
| Dec 31, 2022 | -201.65% |
| Sep 30, 2022 | 5.65% |
| Jun 30, 2022 | -128.54% |
| Mar 31, 2022 | 44.39% |
| Dec 31, 2021 | 57.32% |
| Sep 30, 2021 | 42.09% |